secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001104659-24-009817
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura Pharmaceuticals appoints new auditor after Cherry Bekaert termination
---------------------------------------------------------------------------

- Cherry Bekaert LLP terminated as auditor on Jan 30, 2024; no disagreements or reportable events cited.
- Berkowitz, Pollack Brant Advisors + CPAs appointed on Jan 31, 2024 for FY2022 and FY2023 audits.
- Prior auditor PKF Mueller was acquired by Cherry Bekaert in Oct 2023, leading to the withdrawal.
- Company conducted a competitive process to select the new independent registered public accounting firm.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465924009817/0001104659-24-009817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465924009817/tm244971d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-009817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer